Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-12

Clinical Trial Update: Transdermal Nicotine Replacement in Smokers With Acute Aneurysmal Subarachnoid Hemorrhage [NA]

View source ↗

Summary

A completed clinical trial evaluated transdermal nicotine replacement in smokers following an acute aneurysmal subarachnoid hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotine transdermal patch (nicotine patch)

Snippet

Sponsor: Oslo University Hospital | Conditions: Aneurysmal Subarachnoid Hemorrhage | NA | Status: COMPLETED